Agilent, Integrated DNA Technologies to Co-Market qPCR Products | GenomeWeb

This article was originally published on June 15.

By Ben Butkus

Agilent Technologies and Integrated DNA Technologies have agreed to co-market their qPCR reagents, assays, and instrumentation, Agilent said today.

Under the agreement, the companies will co-market Agilent's Mx3005P qPCR system and Brilliant qPCR reagents with IDT's PrimeTime qPCR assays.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.